SEC-sourced researchBeta
MGNX
MACROGENICS INC
Company comparison ↗
Data passport
- CIK
- 0001125345
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 7, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 58,749,000.0000 | Mar 9, 2026 |
| December 2024 | 149,962,000.0000 | Mar 9, 2026 |
| December 2025 | 149,500,000.0000 | Mar 9, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 149,500,000.0000 | -74,620,000.0000 | -81,040,000.0000 | 256,846,000.0000 | 201,255,000.0000 | Mar 9, 2026 |
| December 2024 | 149,962,000.0000 | -66,966,000.0000 | -68,373,000.0000 | 261,655,000.0000 | 145,598,000.0000 | Mar 9, 2026 |
| December 2023 | 58,749,000.0000 | -9,058,000.0000 | -78,205,000.0000 | — | — | Mar 9, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $149.5M | December 2025 | Mar 9, 2026 | 10-K |
| Previous period revenueRevenues | $149.96M | December 2024 | Mar 9, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$74.62M | December 2025 | Mar 9, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$81.04M | December 2025 | Mar 9, 2026 | 10-K |
| Total assetsAssets | $256.85M | December 2025 | Mar 9, 2026 | 10-K |
| Total liabilitiesLiabilities | $201.26M | December 2025 | Mar 9, 2026 | 10-K |